General Endocrinology

Latest News

Running May Reduce All-Cause Mortality, Regardless of Frequency

By

Brandon May

Running for physical fitness or recreation is associated with a 27% decrease in the risk for all-cause mortality, a study in the British Journal of Sports Medicine suggests.

General Fertility Rate Declined in United States in 2018

The general fertility rate declined to 59.1 births per 1,000 women aged 15 to 44 years in 2018 in the United States.

Low BMD Linked to SHBG Levels in Postmenopausal Women With T2D

By

Hannah Dellabella

Women with higher serum SHBG had an increased risk for osteoporosis, osteopenia, and fracture.

Long-Term Efficacy of Temozolomide Not Seen for Pituitary Tumors, Carcinomas

By

Laurell Haapanen

Despite promising early response rates to the oral chemotherapy drug temozolomide for aggressive pituitary tumors and carcinomas, long-term efficacy is less likely.

New Formulation of Tesamorelin Available for Patients With HIV and Lipodystrophy

By

Diana Ernst, RPh

Egrifta SV is indicated for the reduction of excess abdominal fat in HIV-infected adult patients with lipodystrophy.

How Do Disease Activity, Treatment Affect Risk for Sleep Apnea in Acromegaly?

By

Amit Akirov, MD

The prevalence of obstructive sleep apnea in patients with acromegaly is similar in the presence of active or inactive disease.

Few Women With Chronic Health Issues Use Reliable Birth Control

One in three women of reproductive age have a chronic condition that could compromise their health or lead to adverse outcomes during pregnancy, yet few use the most effective forms of contraception.

Case Study: Management of Residual Disease After Surgery for Acromegaly

By

Amit Akirov, MD

A woman presents with elevated IGF-1 levels after transsphenoidal resection of pituitary tumor. What is the best approach to treatment in this case?

Lower Education, Hepatitis C Co-Infection Linked to Earlier Menopause in HIV

By

Hannah Dellabella

In women with HIV, lower education and hepatitis C co-infection are independently associated with the onset of menopause before age 45 years.

Adolescent Girls Using Oral Contraceptives Have Higher Self-Reported Depressive Symptoms

By

Brandon May

Symptoms of depression are associated with oral contraceptive use in 16-year-old girls compared with adolescents and young women up to 25 years of age.

Stress and HPA Axis Function Interact in Adolescent Depression

By

Laurel Ranger

According to the authors, this study distinguishes itself from others given its focus on cumulative exposure to cortisol rather than acute circulating levels.